Difference between revisions of "Part:BBa K2918003"
Hafsaflats (Talk | contribs) (→Characterization) |
Weronika77 (Talk | contribs) (→Characterization) |
||
Line 55: | Line 55: | ||
The intensity of the mass spectrographs shown in Figure 2 only reflect the <I>occurrence</I> of a given sequence in the sample. These peptide sequences were only present in the samples that were expected. The difference in height can be attributed to the strength of the promoters, less peptides were measured with decreasing strength. For the first peptide <i>GEPVQVVSVEPNTEVYELPVEK</i>, the intensity of DSB with Medium promoter and the Weak promoter were 57% and 35% of the intensity of the WT promoter respectively. For the second peptide <i>FLEVATVR</I> it is 82% and 35% respectively. In conclusion, the results were positive and the identity of the proteins could be further confirmed by mass spectrometry. | The intensity of the mass spectrographs shown in Figure 2 only reflect the <I>occurrence</I> of a given sequence in the sample. These peptide sequences were only present in the samples that were expected. The difference in height can be attributed to the strength of the promoters, less peptides were measured with decreasing strength. For the first peptide <i>GEPVQVVSVEPNTEVYELPVEK</i>, the intensity of DSB with Medium promoter and the Weak promoter were 57% and 35% of the intensity of the WT promoter respectively. For the second peptide <i>FLEVATVR</I> it is 82% and 35% respectively. In conclusion, the results were positive and the identity of the proteins could be further confirmed by mass spectrometry. | ||
+ | |||
+ | ===Toxicity=== | ||
+ | |||
+ | Our Sci-Phi 29 tool is based on four components of the Φ29 bacteriophage: DNAP, TP, p5 and p6. However, overexpression of these proteins are toxic for the cell. In order to determine the optimal expression levels of the proteins in live cells, we carried out viability assays in <i>E. coli</i> BL21(DE3) pLysS. The results are shown in the graphs below. | ||
+ | |||
+ | <div><ul> | ||
+ | <li style="display: inline-block;"> [[File:T--TUDelft--noiptgp6.png|thumb|none|444px|<b>Figure 3A:</b> The growth curve of phi29 p6 under different promoter strengths (weak, medium, Wild-Type) with no IPTG induction]] </li> | ||
+ | <li style="display: inline-block;"> [[File:T--TUDelft--1iptgp6.png |thumb|none|444px|<b>Figure 3B:</b> The growth curve of phi29 p6 under different promoter strengths (weak, medium, Wild-Type) with 1 mM IPTG induction]] </li> | ||
+ | <li> [[File:T--TUDelft--10iptgp6.png|thumb|center|444px|<b>Figure 3C:</b> The growth curve of phi29 p6 under different promoter strengths (weak, medium, Wild-Type) with 10 mM IPTG induction]] </li> | ||
+ | </ul></div> | ||
===Strain Construction=== | ===Strain Construction=== |
Revision as of 08:37, 21 October 2019
Φ29 Double Stranded Binding Protein (DSB/p6)
Double Stranded Binding protein of the Φ29 bacteriophage
Sequence and Features
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal AgeI site found at 168
- 1000COMPATIBLE WITH RFC[1000]
The part has been confirmed by sequencing and there are no mutations.
Usage and Biology
The Φ29 replication mechanism involves replication of a protein-primed based replication linear DNA. Protein primed replication, unlike the conventional DNA or RNA primed mechanism, do not depend on specific sequences of DNA/RNA and simplifies the design of replication systems. The Φ29 replication can be established by using four simple proteins: Φ29 DNA polymerase ( (DNAP/p2)